Bacterial Resistance Clinical Trial
Official title:
Impact of Antistaphylococcal Penicillins and Cefazolin on the Emergence of Resistance in French Hospitals
Antistaphylococcal penicillins are recommanded as first-line agent in methicillin-suceptible Staphylococcus aureus bacteraemia. Several studies in progress are investigating the efficacy and safety of cefazolin compared with antistaphylococcal penicillins. Cefazolin has broader spectrum than antistaphylococcal penicillins. The hypothesis of this project is that cefazoline could be responsible for a higher rate of bacterial resistance. The aim is to study the association between the emergence of bacterial resistance and the consumption of cefazolin and antistaphylococcal penicillins.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02223338 -
Bacterial Resistance in Patients Receiving Post-Intravitreal Injection Antibiotics
|
N/A | |
| Active, not recruiting |
NCT03226314 -
Community Epidemiology and Typology of Third-generation Cephalosporins Resistant Enterobacteriaceae in Reunion Island
|
||
| Active, not recruiting |
NCT01208519 -
SATURN 04 Nosocomial Acquisition Study
|
N/A | |
| Completed |
NCT03998865 -
Bacterial Microbiota Characterization on Implant-supported PEEK and Titanium Provisional Abutments
|
N/A | |
| Not yet recruiting |
NCT03752476 -
Impact of Number of Rank of B-lactam Antibiotics on Emergence on Multidrug Resistant Bacteria
|
||
| Completed |
NCT02641015 -
Study to Assess Management and Outcomes of Hospitalised Patients With Complicated UTI (RESCUING)
|
N/A | |
| Completed |
NCT01878643 -
Reduction of Bacterial Resistance With Inhaled Antibiotics in the Intensive Care Unit
|
Phase 0 |